IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomas

被引:0
|
作者
Amit Akirov
Yona Greenman
Benjamin Glaser
Irena S’chigol
Yossi Mansiterski
Yoav Eizenberg
Ilana Shraga-Slutzky
Ilan Shimon
机构
[1] Beilinson Hospital,Institute of Endocrinology, Rabin Medical Center
[2] Tel Aviv University,Sackler School of Medicine
[3] Tel Aviv Sourasky Medical Center,Institute of Endocrinology, Metabolism and Hypertension
[4] Hadassah-Hebrew University Medical Center,Endocrinology and Metabolism Service
[5] Clalit Health Care Services,undefined
[6] Maccabi Health Care Services,undefined
[7] Tel Aviv-Jaffa District Clalit Health Services,undefined
来源
Pituitary | 2018年 / 21卷
关键词
Acromegaly; Dopamine agonist; IGF-1; Prolactinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:406 / 413
页数:7
相关论文
共 50 条
  • [1] IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomas
    Akirov, Amit
    Greenman, Yona
    Glaser, Benjamin
    S'chigol, Irena
    Mansiterski, Yossi
    Eizenberg, Yoav
    Shraga-Slutzky, Ilana
    Shimon, Ilan
    PITUITARY, 2018, 21 (04) : 406 - 413
  • [2] Dopamine agonist resistant prolactinomas: any alternative medical treatment?
    P. Souteiro
    N. Karavitaki
    Pituitary, 2020, 23 : 27 - 37
  • [3] Dopamine agonist resistant prolactinomas: any alternative medical treatment?
    Souteiro, P.
    Karavitaki, N.
    PITUITARY, 2020, 23 (01) : 27 - 37
  • [4] Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment
    Palmieri, Viviana Valeria
    Lonero, Antonella
    Bocchini, Sarah
    Cassano, Gilda
    Convertino, Alessio
    Corica, Domenico
    Crino, Antonio
    Fattorusso, Valentina
    Ferraris, Silvio
    Fintini, Danilo
    Franzese, Adriana
    Grugni, Graziano
    Iughetti, Lorenzo
    Lia, Rosanna
    Macchi, Francesca
    Madeo, Simona Filomena
    Matarazzo, Patrizia
    Nosetti, Luana
    Osimani, Sara
    Pajno, Roberta
    Patti, Giuseppa
    Pellegrin, Maria Chiara
    Perri, Annamaria
    Ragusa, Letizia
    Rutigliano, Irene
    Sacco, Michele
    Salvatoni, Alessandro
    Scarano, Emanuela
    Stagi, Stefano
    Tornese, Gianluca
    Trifiro, Giuliana
    Wasniewska, Malgorzata
    Fischetto, Rita
    Giordano, Paola
    Licenziati, Maria Rosaria
    Delvecchio, Maurizio
    GROWTH HORMONE & IGF RESEARCH, 2019, 48-49 : 9 - 15
  • [5] IGF-1 plasma levels evaluation in prolactinoma
    Zylberberg, Daniela
    Naliato, Erika C. O.
    Sarmet, Alair
    Sato, Eduardo
    Costa, Fernando S. R.
    Violante, Alice H. D.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2006, 64 (3B) : 849 - 854
  • [6] Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal
    Santharam, Sandhya
    Fountas, Athanasios
    Tampourlou, Metaxia
    Arlt, Wiebke
    Ayuk, John
    Gittoes, Neil
    Toogood, Andrew
    Karavitaki, Niki
    CLINICAL ENDOCRINOLOGY, 2018, 89 (03) : 346 - 353
  • [7] Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps
    Soubry, Adelheid
    Il'yasova, Dora
    Sedjo, Rebecca
    Wang, Frances
    Byers, Tim
    Rosen, Clifford
    Yashin, Anatoli
    Ukraintseva, Svetlana
    Haffner, Steven
    D'Agostino, Ralph, Jr.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (02) : 512 - 517
  • [8] The alteration of IGF-1 levels and relationship between IGF-1 levels and growth velocity during GnRH analogue therapy
    Sahin, Nursel Muratoglu
    Kendirci, Havva Nur Peltek
    Cetinkaya, Semra
    Erdeve, Senay Savas
    Aycan, Zehra
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (01) : 113 - 120
  • [9] IGF-1 Gene Therapy as a Potentially Useful Therapy for Spontaneous Prolactinomas in Senile Rats
    Brown, Oscar A.
    Canatelli-Mallat, Martina
    Console, Gloria M.
    Camihort, Gisela
    Luna, Georgina
    Spinedi, Eduardo
    Goya, Rodolfo G.
    CURRENT GENE THERAPY, 2018, 18 (04) : 240 - 245
  • [10] Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels
    Temmerman, L.
    Slonimsky, E.
    Rosenthal, N.
    GROWTH HORMONE & IGF RESEARCH, 2010, 20 (03) : 255 - 263